Skip to main content

clofarabine

Generic: CLOFARABINE·Brand: CLOFARABINE, CLOLAR, Clolar

clofarabine: sourced relationships with 1 company · 4 clinical trials tracked · 1 FDA decision.

clofarabine evidence translation

What we can confirm

1 FDA record · 4 tracked trials

What it means

Source-backed records connect clofarabine to RDY; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could clofarabine → RDY affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (1)
CompanyDated record stage
DR REDDYS LABORATORIES LTD (RDY)
Reported 2017-11-06 · Current development: unknownSource
Approved
Clinical Trial Registry Records (4)

A Phase lb Study of Vyxeos® (Liposomal Daunorubicin and Cytarabine) in Combination With Clofarabine in Children With Relapsed/Refractory AML, ITCC-092

NCT07156435Registry updated 2025-09-05·Phase 1
Recruiting

Primary endpoint: Dose finding for combination Vyxeos® with clofarabine

Interventionalopen25 targetStarted 2020-11Completion 2028-1213 sites · Austria, Denmark, Germany, Italy…Princess Maxima Center for Pediatric Oncology

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

NCT03117751Registry updated 2026-06-17·Phase 2/Phase 3
Active, not recruiting

Primary endpoint: Event-free survival of ALL patients (EFS)

InterventionalRandomizedsingle790 targetStarted 2017-03Completion 2028-098 sites · Australia, United StatesSt. Jude Children's Research Hospital

Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders

NCT02425904Registry updated 2026-06-23·Phase 2
Active, not recruiting

Primary endpoint: Response Rate (OR) of LCH Cohort

Interventionalopen25 targetStarted 2015-05Completion 2026-1215 sites · Canada, United StatesDana-Farber Cancer Institute

Phase II Study of Clofarabine and High-Dose Melphalan Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation for Myelodysplasia or Acute Leukemia in Remission

NCT01885689Registry updated 2026-08-27·Phase 2
Active, not recruiting

Primary endpoint: Progression-free Survival at 2 Years

Interventionalopen72 enrolledStarted 2014-02Completion 2026-091 site · United StatesCity of Hope Medical Center
FDA Decisions1 records
Approval(RDY)FDA ↗
ANDA205375UNKNOWNStandardIntravenousSolution

Frequently asked questions

Which companies have sourced relationships with clofarabine?

clofarabine has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD.

How many clinical trials involve clofarabine?

BioSniper tracks 4 clinical trials involving clofarabine.

What is clofarabine's latest FDA decision?

The most recent tracked FDA decision for clofarabine is Approval, dated November 6, 2017.